Gets sued.
The medication is approved to treat two rare blood diseases that affect about one in every one million people. A 12-month treatment costs about $700,000 in Canada, while in the U.S. it costs about $669,000.
Soliris is the only drug Alexion produces, but it's earned the firm revenues of more than $6 billion over eight years.
The medication is approved to treat two rare blood diseases that affect about one in every one million people. A 12-month treatment costs about $700,000 in Canada, while in the U.S. it costs about $669,000.
Soliris is the only drug Alexion produces, but it's earned the firm revenues of more than $6 billion over eight years.